Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Results
Statement
More
| Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
| 20.03 |
20.03 |
20.00 |
20.00 |
20.00 |
Share application money
Preference share capital
Reserves & surplus
| 482.44 |
412.85 |
344.95 |
284.49 |
242.60 |
Secured loans
| 2.00 |
2.04 |
0.14 |
4.35 |
31.79 |
Unsecured loans
Total
| 504.47 |
434.92 |
365.10 |
308.85 |
294.39 |
Gross block
| 196.54 |
170.27 |
111.78 |
107.55 |
100.19 |
Less : revaluation reserve
Less : accumulated depreciation
| 46.01 |
38.39 |
21.88 |
16.52 |
11.74 |
Net block
| 150.53 |
131.88 |
89.90 |
91.03 |
88.45 |
Capital work-in-progress
| 6.71 |
16.05 |
1.34 |
0.04 |
1.94 |
Investments
| 91.38 |
96.86 |
106.40 |
60.00 |
45.81 |
Current assets, loans & advances
| 338.63 |
289.32 |
241.05 |
216.14 |
210.59 |
Less : current liabilities & provisions
| 82.78 |
99.19 |
73.59 |
58.36 |
52.40 |
Total net current assets
| 255.85 |
190.13 |
167.45 |
157.78 |
158.19 |
Miscellaneous expenses not written
Total
| 504.47 |
434.92 |
365.10 |
308.85 |
294.39 |
Book value of unquoted investments
| 91.33 |
96.86 |
19.98 |
20.03 |
21.98 |
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
| 200.30 |
200.30 |
200.00 |
200.00 |
200.00 |